Market Research Logo

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2017 Update


Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Anika Therapeutics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Anika Therapeutics Inc Company Overview
Anika Therapeutics Inc Company Snapshot
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Anika Therapeutics Inc – Pipeline Analysis Overview
Business Description
Anika Therapeutics Inc - Key Facts
Anika Therapeutics Inc - Major Products and Services
Anika Therapeutics Inc Pipeline Products by Development Stage
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status
Anika Therapeutics Inc Pipeline Products Overview
Cingal Product Overview
Cronofill Product Overview
Hemostatic Patch
Hemostatic Patch Product Overview
HYAFF Barrier Film
HYAFF Barrier Film Product Overview
HYAFF Gel Product Overview
HYAFF Mesh Product Overview
HYAFF/ACP Spray - Adhesion
HYAFF/ACP Spray - Adhesion Product Overview
Hyalobone Product Overview
Hyalofast Product Overview
Hyalofast Clinical Trial
Hyaloglide Product Overview
Hyalograft C Autograft
Hyalograft C Autograft Product Overview
Hyalonect Product Overview
MONOVISC Product Overview
MONOVISC - Hip Product Overview
MONOVISC - Hip Clinical Trial
Next Generation ELEVESS Dermal Filler
Next Generation ELEVESS Dermal Filler Product Overview
ORTHOVISC-T Product Overview
Anika Therapeutics Inc - Key Competitors
Anika Therapeutics Inc - Key Employees
Anika Therapeutics Inc - Key Employee Biographies
Anika Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Anika Therapeutics Inc, Recent Developments
Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
Dec 19, 2016: Anika Wins CE Mark Approval For ORTHOVISC-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury
Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
Sep 22, 2016: Anika Announces Data Presentations on HYALOFAST Hyaluronic Acid-Based Scaffold at 2016 World Congress of the International Cartilage Repair Society
Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results
Jun 01, 2016: Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis
May 19, 2016: Pendopharm Announces Canadian Launch Of Cingal In Partnership With Anika Therapeutics
Apr 27, 2016: Anika Reports First Quarter 2016 Financial Results
Apr 04, 2016: Anika Appoints New Chief Medical Officer and Chief Operations Officer
About GlobalData
Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report